Skip to main content

Idhifa

enasidenib
Used for Leukemia

Idhifa (enasidenib) is a targeted therapy used to treat acute myeloid leukemia (AML). But Idhifa (enasidenib) is only for adults who've a specific mutation in the IDH2 protein. This medication is taken by mouth, typically once daily. It can cause side effects such as nausea, diarrhea, and a serious condition called differentiation syndrome.

Reviewed by:Last reviewed on September 22, 2023
basics-icon

What is Idhifa (enasidenib)?

What is Idhifa (enasidenib) used for?

How Idhifa (enasidenib) works

Acute myeloid leukemia (AML) is caused by gene changes (mutation) that prevent immature blood cells from developing into healthy cells. Instead, these cells turn into cancer cells. Some people with AML have a mutation in the gene that makes the isocitrate dehydrogenase 2 (IDH2) protein.

Idhifa (enasidenib) is an IDH2 inhibitor. When Idhifa (enasidenib) blocks IDH2, it lowers the number of cancer cells and allows the young blood cells to mature into healthy cells .

Drug facts

Common BrandsIdhifa
Drug ClassIDH2 Inhibitor
Controlled Substance ClassificationNot a controlled medication
Generic StatusNo lower-cost generic available
AvailabilityPrescription only
side-effects-icon

Side effects of Idhifa (enasidenib)

The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.

Common Side Effects

Less Common Side Effects

Idhifa (enasidenib) serious side effects

Contact your healthcare provider immediately if you experience any of the following.

  • Differentiation syndrome: fever, sudden weight gain, trouble breathing, chest pain, swelling in legs

Source: DailyMed

The following Idhifa (enasidenib) side effects have also been reported

Side effects that you should report to your care team as soon as possible:

  • Allergic reactions—skin rash, itching, hives, swelling of the face, lips, tongue, or throat
  • Fever, cough, dizziness, feeling faint or lightheaded, shortness of breath, bone pain, sudden weight gain, swelling of the ankles, hands, or feet, which may be signs of differentiation syndrome
  • High white blood cell level—fever, fatigue, trouble breathing, night sweats, change in vision, weight loss
  • Liver injury—right upper belly pain, loss of appetite, nausea, light-colored stool, dark yellow or brown urine, yellowing skin or eyes, unusual weakness or fatigue
  • Tumor lysis syndrome (TLS)—nausea, vomiting, diarrhea, decrease in the amount of urine, dark urine, unusual weakness or fatigue, confusion, muscle pain or cramps, fast or irregular heartbeat, joint pain

Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):

pros-and-cons-icon

Pros and cons of Idhifa (enasidenib)

Pros

  • Taken by mouth, so good for people who don’t like needles
  • Recommended treatment for certain people with AML and an IDH2 mutation
  • Works in a more specific, targeted way than traditional chemotherapy

Cons

  • Might interact with other oral medications, such as birth controls
  • Can’t be used in people who don’t have an IDH2 mutation
  • Can cause a serious side effect called differentiation syndrome
pharmacist-tips-icon

Pharmacist tips for Idhifa (enasidenib)

pharmacist
  • Based on animal studies, there’s a possibility that taking Idhifa (enasidenib) might affect your fertility. In other words, it may make it more difficult for you to have children. If you’re concerned about being able to have children in the future, talk to your provider before starting Idhifa (enasidenib).
  • Check your body temperature regularly, ideally once a day. Call your provider immediately if your temperature is 100.4 degrees Fahrenheit or higher; this means you have a fever. Sometimes a fever might be the only sign that you’re sick.
  • Take Idhifa (enasidenib) around the same time each day. You can take it with or without food, but make sure to take the tablets whole and do not crush or split them. If you miss a dose and remember that same day, go ahead and take it. If you miss a dose and it’s already the next day, just skip it and start with your next scheduled dose.
  • Females who are taking Idhifa (enasidenib)] should avoid breastfeeding during treatment and for 2 months after the last dose. We don’t know whether Idhifa (enasidenib)] is found in breast milk and whether it affects breastfed babies, but there’s a possible risk of harm to a baby.
  • It’s possible that Idhifa (enasidenib) can cause hormonal birth control pills not work as well. If you’re a female able to have children, talk to your provider about which birth control is best for you. Your provider might recommend a non-hormonal birth control option.
  • Ask your provider about the best way to handle and throw away Idhifa (enasidenib) safely. Anticancer medications can be harmful to people who handle or come in contact with them. You should store the medication up and away, so children and pets won’t be able to reach it.
  • You might experience some diarrhea when you first start Idhifa (enasidenib) treatment, but this should improve over time. Your provider might suggest an over-the-counter medication, like loperamide (Imodium A-D), to help manage diarrhea. If you have diarrhea, it’s important to drink a lot of fluids to stay hydrated and to replace the liquids you've lost. But try to avoid sugary sports drinks because they can make diarrhea worse.
warnings-icon

Risks and warnings for Idhifa (enasidenib)

Idhifa (enasidenib) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.

Differentiation syndrome

Warning Icon Some people taking Idhifa (enasidenib) experienced a serious immune reaction called differentiation syndrome. This side effect can happen up to 5 months after starting treatment, but sometimes as early as after the first dose. Differentiation syndrome is a medical emergency and must be treated right away. Treatment typically involves corticosteroids, such as dexamethasone. Sometimes you might also require medications to help keep your blood pressure in a normal range. If you have any of the symptoms of differentiation syndrome, including fever, trouble breathing, rapid weight gain, chest pain, bone pain, and low blood pressure, seek medical attention right away.

Harm to unborn baby

Based on animal studies, Idhifa (enasidenib) might harm an unborn baby or raise the risk for miscarriage (pregnancy loss). Because of these risks, if you’re a female who can get pregnant, you should use birth control while taking Idhifa (enasidenib) and for 2 months after the last dose. Your provider might require a negative pregnancy test before you start treatment. Let your provider know right away if you become pregnant while taking Idhifa (enasidenib).

If you’re a male who's sexually active with a partner who can get pregnant, you should use condoms while taking Idhifa (enasidenib) and for 2 months after the last dose.

dosage-icon

Idhifa (enasidenib) dosage

Typical dosage for Idhifa (enasidenib)

The typical dose is 100 mg by mouth once a day.

References

Best studies we found

Adeyinka, A., et al. (2022). Tumor lysis syndrome. StatPearls.

American Cancer Society. (2019). Chemotherapy safety.

American Cancer Society. (2020). Fever.

GoodRx Health has strict sourcing policies and relies on primary sources such as medical organizations, governmental agencies, academic institutions, and peer-reviewed scientific journals. Learn more about how we ensure our content is accurate, thorough, and unbiased by reading our editorial guidelines.